Bayer Teams Up With Versant Ventures to Develop Stem-Cell Therapies – Wall Street Journal
Wall Street Journal |
Bayer Teams Up With Versant Ventures to Develop Stem–Cell Therapies
Wall Street Journal FRANKFURT—German pharmaceuticals giant Bayer AG and U.S. health care investor Versant Ventures plan to establish a stem–cell research company, marking the latest effort by a big pharmaceutical company to develop new and innovative drugs by … |
